A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2021) Kovakantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2021) Kovakantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2022) Kovakantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2022) Kovakantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2022) Pehmeäkantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2023) Kovakantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2023) Kovakantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2022) Pehmeäkantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2023) Pehmeäkantinen kirja
A. Douglas Kinghorn; Heinz Falk; Simon Gibbons; Yoshinori Asakawa; Ji-Kai Liu; Verena M. Dirsch Springer International Publishing AG (2023) Kovakantinen kirja
A. Douglas Kinghorn; Heinz Falk; Simon Gibbons; Yoshinori Asakawa; Ji-Kai Liu; Verena M. Dirsch Springer International Publishing AG (2023) Kovakantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2023) Pehmeäkantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2024) Kovakantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2024) Pehmeäkantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2024) Pehmeäkantinen kirja
A. Douglas Kinghorn; Heinz Falk; Simon Gibbons; Yoshinori Asakawa; Ji-Kai Liu; Verena M. Dirsch Springer International Publishing AG (2024) Kovakantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2024) Kovakantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2024) Pehmeäkantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2024) Pehmeäkantinen kirja
A. Douglas Kinghorn (ed.); Heinz Falk (ed.); Simon Gibbons (ed.); Yoshinori Asakawa (ed.); Ji-Kai Liu (ed.); Verena Dirsch Springer (2025) Kovakantinen kirja
This book describes current understandings and recent progress into a varied group of natural products. In the first chapter the role that total synthesis may play in revising the structures proposed for decanolides, which are ten-membered lactones found primarily in fungi, frogs, and termites is presented. The following chapter presents the development of the intriguing plant-derived sesquiterpene lactone, thapsigargin, a potent inhibitor of the enzyme, SERCA (sarco-endoplasmic Ca2+ ATPase), which has potential as a lead compound to treat cancer. The third chapter covers the potential of various plant phenolic compounds for treating the tropical and sub-tropical infectious disease, leishmaniasis. In addition the volume presents recent advances related to the plant alkaloid, cryptolepine, which is of particular interest as a lead for the treatment of malaria, trypanosomiasis, and cancer.
